Labs / ADME, DMPK & toxicology
Ajinomoto Bio-Pharma Services
San Diego, CA, United States · ajibio-pharma.ajinomoto.com
GLP · GMP
Ajinomoto Bio-Pharma Services is a global network of specialized CDMOs serving biopharma programs across small molecules, oligonucleotides, peptides, gene therapy, proteins, and bioconjugates. It operates sites in Belgium, India, Japan, and the United States and supports development and manufacturing for clients worldwide.
Their website has a general contact form; we send your quote request through it.
What they offer
Small Molecule Manufacturing
Develops and manufactures APIs and intermediates, including specialized solutions for complex chemistry.
Oligonucleotide Manufacturing
Provides solid-phase synthesis and AJIPHASE™ liquid-phase technology for oligonucleotide development and manufacturing.
Peptide Manufacturing
Produces complex and high-volume peptides, including GLP-1 analogs.
Gene Therapy Manufacturing
Supports AAV development and GMP manufacturing through Forge Biologics.
Protein Manufacturing
Produces recombinant proteins through secretion for simplified purification and higher purity.
ADC & Bioconjugation Services
Provides site-specific conjugation and linker technologies for ADCs and other bioconjugates.
Continuous Flow Chemistry
Offers continuous flow chemistry services for small molecule development and manufacturing.
High Potency API Manufacturing
Provides manufacturing support for high potency APIs.
Research-Grade Oligonucleotides
Offers research-grade oligonucleotide products.
Clinical & Commercial Oligonucleotide Manufacturing
Supports oligonucleotide programs from clinical development through commercial supply.
Site-Specific Conjugation Technology
Uses AJICAP™ to enable site-specific antibody conjugation and linker attachment.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, ADC, Peptide, Oligonucleotide, mRNA, Viral vector, Recombinant protein, LNP / formulation
- Species and models
- Corynebacterium glutamicum, native IgG antibodies
- Assays and studies
- analytical characterization, process optimization, method validation, stability studies, product characterization
- Instruments and platforms
- IEX, RP-LC, UF/DF
- Scale and capacity
- solid-phase synthesis from μg to several kg, AJIPHASE™ up to 200 kg/batch, gr grams to 200 kg/batch, largest reactor used in GMP manufacturing: 8,000L, enzymatic siRNA synthesis from several kilograms up to 200 kg, GenClip™ long RNA from 100 to 500 mer
- Type
- CRDMO
- Sites
- Wetteren, Belgium · Osaka, Japan · Belgium, Belgium · India, India · Japan, Japan · United States, United States
- Team
- 2,000+ employees worldwide
- Quality
- GMP (oligonucleotide manufacturing) · ICH guidelines (stability programs) · PMDA audited (Osaka oligonucleotide site)
- Serves
- worldwide
Public records
Similar labs. Aurigene Pharmaceutical Services, Sparx BIO, Sai Life, Transcenta Holding
Found in the Biocom California CRO directory. Listing built from ajibio-pharma.ajinomoto.com. Work here? Claim this listing.